advertisement

WGC-2021

11.14 Investigational drugs; pharmacological experiments (87)

Showing records 1 to 25

Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments

Search within classification 11.14 Investigational drugs; pharmacological experiments
91192 Intraocular pressure-lowering effects of ripasudil, a rho-kinase inhibitor, and selective laser trabeculoplasty as adjuvant therapy in patients with uncontrolled glaucoma
Ono K
International Ophthalmology 2021; 41: 605-611
91857 Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
Zhang Y
Experimental Eye Research 2021; 204: 108449
91788 Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma
Manabe K
Journal of clinical biochemistry and nutrition 2021; 68: 67-72
90997 Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
Singh IP
Journal of Glaucoma 2020; 29: 878-884
91139 ROCK inhibitors beneficially alter the spatial configuration of TGFβ2-treated 3D organoids from a human trabecular meshwork (HTM)
Ota C
Scientific reports 2020; 10: 20292
91117 Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
Wang Y
Clinics 2020; 75: e1874
91635 Netarsudil for the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Literature Review
Gonzalez LE
Annals of Pharmacotherapy 2020; 0: 1060028020971215
91775 Effect of Rho Kinase Inhibitor Ripasudil (K-115) on Isolated Porcine Retinal Arterioles
Kamiya T
Journal of Ocular Pharmacology and Therapeutics 2021; 37: 104-111
91371 Trabodenoson on trabecular meshwork rejuvenation: a comprehensive review of clinical data
Qiu TG
Expert Opinion on Investigational Drugs 2021; 30: 227-236
91467 A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma
Peace JH
Ophthalmology and therapy 2021; 10: 89-100
91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Lorenzo-Soler L
Acta Ophthalmologica 2020; 0:
91674 Rho kinase inhibitors as new local therapy option in primary open angle glaucoma
Erb C
Ophthalmologe 2021; 0:
91292 Reticular Epithelial Edema: An Uncommon Side Effect of ROCK/NET Inhibitor Netarsudil
Chen H
Journal of Glaucoma 2020; 29: e124-e126
91403 Intraocular pressure-lowering effect of mycelia extract in a glaucoma rat model
Horng CT
International journal of medical sciences 2021; 18: 1007-1014
91050 The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma
Jayanetti V
Journal of experimental pharmacology 2020; 12: 539-548
91831 Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis
Harasymowycz P
British Journal of Ophthalmology 2021; 0:
91664 Effects of Ripasudil on Open-Angle Glaucoma after Circumferential Suture Trabeculotomy Ab Interno
Sato T
Journal of clinical medicine 2021; 10:
91410 Cannabinoids in Glaucoma Patients: The Never-Ending Story
Passani A
Journal of clinical medicine 2020; 9:
90997 Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
Fechtner RD
Journal of Glaucoma 2020; 29: 878-884
91117 Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
Liao Y
Clinics 2020; 75: e1874
91664 Effects of Ripasudil on Open-Angle Glaucoma after Circumferential Suture Trabeculotomy Ab Interno
Kawaji T
Journal of clinical medicine 2021; 10:
91050 The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma
Sandhu S
Journal of experimental pharmacology 2020; 12: 539-548
91674 Rho kinase inhibitors as new local therapy option in primary open angle glaucoma
Konieczka K
Ophthalmologe 2021; 0:
91846 Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure
Olafsdottir OB
Acta Ophthalmologica 2020; 0:
91192 Intraocular pressure-lowering effects of ripasudil, a rho-kinase inhibitor, and selective laser trabeculoplasty as adjuvant therapy in patients with uncontrolled glaucoma
Sakemi F
International Ophthalmology 2021; 41: 605-611

Issue 21-4

Change Issue


advertisement

WGC-2021